Indo Us Biotech Limited Stock Price Today (NSE: INDOUS)
Fundamental Score
Indo Us Biotech Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Indo Us Biotech Limited share price today is ₹77.16, down 1.44% on NSE/BSE as of 16 September 2026. Indo Us Biotech Limited (INDOUS) is a Small-cap company in the Other Agricultural Products sector with a market capitalisation of ₹154.72 (Cr). The 52-week high for INDOUS share price is ₹159.00 and the 52-week low is ₹70.00. At a P/E ratio of 13.54x, INDOUS is currently trading below its industry average P/E of 19.03x. The company has a Return on Equity (ROE) of 15.34% and a debt-to-equity ratio of 0.40.
Indo Us Biotech Limited Share Price Chart — NSE/BSE Historical Performance
Indo Us Biotech Limited share price chart: -2.38% return over the past month. 52-week high ₹159.00, 52-week low ₹70.00.
Indo Us Biotech Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹81.00 | ₹81.00 | ₹76.10 | ₹77.16 | 3.84K (Cr) | |
| ₹79.90 | ₹81.00 | ₹76.00 | ₹78.29 | 2.24K (Cr) | |
| ₹82.00 | ₹82.00 | ₹78.00 | ₹78.24 | 10.16K (Cr) | |
| ₹81.20 | ₹81.25 | ₹78.01 | ₹79.54 | 5.67K (Cr) | |
| ₹81.33 | ₹81.33 | ₹78.00 | ₹80.25 | 18.72K (Cr) | |
| ₹78.81 | ₹83.00 | ₹78.05 | ₹78.85 | 13.63K (Cr) | |
| ₹77.48 | ₹79.95 | ₹75.96 | ₹78.74 | 5.68K (Cr) | |
| ₹77.02 | ₹79.78 | ₹70.00 | ₹77.48 | 41.73K (Cr) | |
| ₹78.15 | ₹81.99 | ₹78.15 | ₹78.82 | 3.58K (Cr) | |
| ₹79.00 | ₹81.30 | ₹76.05 | ₹78.15 | 5.09K (Cr) |
Indo Us Biotech Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹82.72 | ₹84.27 | ₹70.00 | ₹77.16 | -6.72% | |
| ₹81.00 | ₹90.88 | ₹74.98 | ₹79.47 | -1.89% | |
| ₹88.88 | ₹91.90 | ₹80.10 | ₹81.62 | -8.17% | |
| ₹98.00 | ₹103.84 | ₹86.16 | ₹87.59 | -10.62% | |
| ₹106.95 | ₹114.00 | ₹98.13 | ₹99.80 | -6.69% | |
| ₹99.00 | ₹112.00 | ₹99.00 | ₹104.27 | +5.32% | |
| ₹142.94 | ₹148.00 | ₹96.05 | ₹98.21 | -31.29% | |
| ₹120.00 | ₹154.39 | ₹120.00 | ₹144.56 | +20.47% | |
| ₹124.00 | ₹133.00 | ₹105.00 | ₹125.22 | +0.98% | |
| ₹133.42 | ₹151.00 | ₹118.00 | ₹121.56 | -8.89% | |
| ₹135.35 | ₹159.00 | ₹109.50 | ₹135.42 | +0.05% | |
| ₹140.00 | ₹144.59 | ₹119.39 | ₹134.31 | -4.06% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Indo Us Biotech Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Indo Us Biotech Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of INDOUS across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Return on Equity (15.34%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (18.46%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (15.56%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 13.54 vs Industry: 19.03)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Consistent Growth Track Record (22.91% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (20.75% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Interest Coverage (7.21x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Healthy Liquidity Position (Current Ratio: 5.31)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Balanced Promoter Holding (70.17%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Profit Decline Concern (-35.41%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Negative Free Cash Flow (₹-16.07 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 0.01%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Indo Us Biotech Limited vs Other Agricultural Products Peers
Peer Comparison - Other Agricultural Products
Compare Indo Us Biotech Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Indo Us Biotech LimitedIndo Us Biotech...Selected✓ INDOUS • 541304 | 47.6/100 | ₹77.16₹77 | ₹154.72₹154.72 | 13.54Average 13.5 Average | 15.34%Good 15.34% Good | 18.46%Good 18.46% Good | 0.40Excellent 0.4 Excellent | 20.75%Excellent 20.75% Excellent | 22.91%Excellent 22.91% Excellent | 0.29% |
LT Foods LimitedLT Foods Limite... LTFOODS • 532783 | 59.6/100 | ₹453.55₹454 | ₹15749.66₹15749.66 | 24.60Average 24.6 Average | 0.00%Poor 0.00% Poor | 20.11%Excellent 20.11% Excellent | 0.22Excellent 0.2 Excellent | 17.99%Excellent 17.99% Excellent | 18.70%Excellent 18.70% Excellent | 0.78% |
KRBL LimitedKRBL Limited... KRBL • 530813 | 45.2/100 | ₹434.45₹434 | ₹9944.56₹9944.56 | 13.11Average 13.1 Average | 11.73%Average 11.73% Average | 15.54%Good 15.54% Good | 0.03Excellent 0.0 Excellent | 2.95%Average 2.95% Average | 8.84%Good 8.84% Good | 0.97% |
Gujarat Ambuja Exports LimitedGujarat Ambuja ... GAEL • 524226 | 45.1/100 | ₹166.39₹166 | ₹7632.31₹7632.31 | 18.35Average 18.3 Average | 9.66%Poor 9.66% Poor | 13.10%Average 13.10% Average | 0.13Excellent 0.1 Excellent | -2.08%Poor -2.08% Poor | 4.01%Average 4.01% Average | 0.17% |
Kaveri Seed Company LimitedKaveri Seed Com... KSCL • 532899 | 51.8/100 | ₹722.05₹722 | ₹3714.15₹3714.15 | 15.04Average 15.0 Average | 18.17%Good 18.17% Good | 18.21%Good 18.21% Good | 0.00Excellent 0.0 Excellent | -0.96%Poor -0.96% Poor | 6.12%Good 6.12% Good | 0.59% |
Sanstar LimitedSanstar Limited... SANSTAR • 544217 | 39.7/100 | ₹108.99₹109 | ₹2182.52₹2182.52 | 45.41Average 45.4 Average | 5.09%Poor 5.09% Poor | 5.51%Poor 5.51% Poor | 0.03Excellent 0.0 Excellent | 19.99%Excellent 19.99% Excellent | 19.85%Excellent 19.85% Excellent | 0.00% |
GRM Overseas LimitedGRM Overseas Li... GRMOVER • 531449 | 40.4/100 | ₹88.14₹88 | ₹1826.35₹1826.35 | 13.95Average 13.9 Average | 14.47%Average 14.47% Average | 23.69%Excellent 23.69% Excellent | 0.61Good 0.6 Good | 10.46%Good 10.46% Good | 18.11%Excellent 18.11% Excellent | 0.00% |
Chaman Lal Setia Exports LimitedChaman Lal Seti... CLSEL • 530307 | 54.6/100 | ₹305.20₹305 | ₹1517.64₹1517.64 | 12.12Average 12.1 Average | 14.61%Average 14.61% Average | 19.04%Good 19.04% Good | 0.10Excellent 0.1 Excellent | 6.96%Good 6.96% Good | 11.07%Good 11.07% Good | 0.89% |
AVT Natural Products LimitedAVT Natural Pro... AVTNPL • 519105 | 58.2/100 | ₹92.42₹92 | ₹1407.41₹1407.41 | 16.80Average 16.8 Average | 0.00%Poor 0.00% Poor | 16.93%Good 16.93% Good | 0.20Excellent 0.2 Excellent | 7.57%Good 7.57% Good | 8.01%Good 8.01% Good | 1.13% |
Gulshan Polyols LimitedGulshan Polyols... GULPOLY • 532457 | 58.1/100 | ₹179.86₹180 | ₹1121.80₹1121.80 | 7.59Average 7.6 Average | 16.09%Good 16.09% Good | 21.93%Excellent 21.93% Excellent | 0.43Excellent 0.4 Excellent | 11.40%Good 11.40% Good | 24.73%Excellent 24.73% Excellent | 0.17% |
53.4/100 | ₹89.42₹89 | ₹938.35₹938.35 | 32.40Average 32.4 Average | 22.68%Excellent 22.68% Excellent | 29.10%Excellent 29.10% Excellent | 0.83Good 0.8 Good | 35.75%Excellent 35.75% Excellent | 14.96%Good 14.96% Good | 0.00% | |
Top Other Agricultural Products Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- LT Foods Limited share price15749.66 Cr
- KRBL Limited share price9944.56 Cr
- Gujarat Ambuja Exports Limited share price7632.31 Cr
- Kaveri Seed Company Limited share price3714.15 Cr
- Sanstar Limited share price2182.52 Cr
Indo Us Biotech Limited PE Ratio History
Historical price-to-earnings ratio for INDOUS — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹8.12 | ₹121.56 | 15x |
| FY 2024 | ₹4.11 | ₹314.90 | 76.6x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Indo Us Biotech Limited Dividend History
Annual cash dividends paid by INDOUS — dividend yield 0.29%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹0.50 Cr |
| FY 2022 | ₹0.15 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Indo Us Biotech Limited Quarterly Performance
Latest quarterly metrics for INDOUS — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
7.21%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-35.41%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
22.91%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
20.75%
Compounded annual net profit growth over 5 years
Indo Us Biotech Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for INDOUS — calculated from daily price history
Selling pressure is heavy — potential reversal zone.
Technical indicators are for educational purposes only. Not investment advice.
Indo Us Biotech Limited Financial Statements
Annual income statement, balance sheet and cash flow for Indo Us Biotech Limited (INDOUS) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Indo Us Biotech Limited
About INDOUS (Indo Us Biotech Limited)
Indo US Bio Tech Ltd is a pioneering force in India's agricultural landscape, specializing in the creation and distribution of high-quality seeds. The company meticulously oversees... every stage, from the initial cultivation and careful processing to the specialized packaging and strategic marketing of its diverse seed portfolio. INDOUS is committed to providing farmers with superior genetic resources, ensuring bountiful harvests and contributing to the nation's food security. They are the backbone of farming communities, constantly innovating to meet the evolving needs of the agricultural industry and setting new standards for seed excellence. Offering a wide spectrum of seed varieties, INDOUS caters to the diverse needs of Indian farmers. Their extensive selection includes a vibrant array of vegetable seeds, from the staple tomato and okra to the more exotic bottle gourd and bitter gourd. In addition to vegetables, INDOUS cultivates and distributes seeds for essential cash crops such as cotton, and vital oilseeds including castor, groundnut, and soybean. The company's commitment to research and development ensures that these seeds are not only high-yielding but also resilient to various environmental challenges, supporting sustainable agricultural practices across the country. Beyond simply selling seeds, INDOUS provides a comprehensive support system for farmers. They believe in empowering the agricultural community through knowledge sharing and innovative solutions. By offering access to premium seeds and practical expertise, INDOUS helps farmers increase their productivity, improve crop quality, and enhance their overall livelihoods. The company actively participates in initiatives that promote sustainable farming practices, contributing to a greener and more prosperous future for Indian agriculture.
Company Details
Key Leadership
INDOUS Share Price: Frequently Asked Questions
What is the current share price of Indo Us Biotech Limited?
Indo Us Biotech Limited (INDOUS) trades at ₹77.16 on NSE and BSE. Market cap ₹154.72 (Cr). Educational data only.
What is the P/E ratio of Indo Us Biotech Limited?
Indo Us Biotech Limited has a P/E of 13.54x vs industry average 19.03x.
What is the Bull Run score for Indo Us Biotech Limited?
Indo Us Biotech Limited has a Bull Run score of 47.6/100 based on 25+ financial parameters.
Does Indo Us Biotech Limited pay dividends?
Indo Us Biotech Limited has a dividend yield of 0.29%. Past dividends don't guarantee future payments.
What is the ROE of Indo Us Biotech Limited?
Indo Us Biotech Limited has ROE of 15.34%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Indo Us Biotech Limited?
Indo Us Biotech Limited has debt-to-equity of 0.40.
Is Indo Us Biotech Limited a good investment?
Bull Run gives Indo Us Biotech Limited a score of 47.6/100. This is not investment advice — consult a SEBI-registered advisor.